For each authorized COVID-19 vaccine, mix-and-match boosters elicited similar or higher antibody responses compared to getting an additional dose of the same vaccine. Emory was among 10 institutions that participated in the study.
This February, in conjunction with the University of Iowa’s 175th anniversary, the Presidential Lecture Series will feature presentations from three distinguished UI faculty members Craig Kletzing, Christopher Merrill, and Patricia Winokur.
世界首款喷气式客机的惨案，解释了飞机窗为什么不是方的 sina.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.cn Daily Mail and Mail on Sunday newspapers.
Tags »
In a randomized, controlled trial of more than 1,000 adults hospitalized with COVID-19 pneumonia, treatment with the anti-inflammatory drug baricitinib resulted in faster recovery and a greater likelihood of clinical improvement, when combined with the antiviral drug remdesivir.
The results of the international ACTT-2 (Adaptive COVID-19 Treatment Trial), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, were published Friday Dec. 11 in the
Baricitinib was originally developed by Eli Lilly and Company for rheumatoid arthritis and was FDA-approved for that indication in 2017. The drug, part of a class of drugs that inhibits JAK enzymes, received an emergency use authorization for COVID-19 treatment in November 2020, based upon the ACTT-2 results.